# Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma

> **NCT05644743** · — · NOT_YET_RECRUITING · sponsor: **Chengjun Sui,MD** · enrollment: 40 (estimated)

## Conditions studied

- Organoids
- Intrahepatic Cholangiocarcinoma

## Interventions

- **DEVICE:** gemcitabine + cisplatin

## Key facts

- **NCT ID:** NCT05644743
- **Lead sponsor:** Chengjun Sui,MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-01
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05644743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05644743, "Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05644743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*